本页面由Tiger Trade Technology Pte. Ltd.提供服务

Denali Therapeutics Inc.

19.41
+0.03000.15%
盘后19.08-0.3300-1.70%18:32 EDT
成交量:119.70万
成交额:2,299.18万
市值:30.78亿
市盈率:-6.54
高:19.53
开:19.23
低:18.80
收:19.38
52周最高:23.77
52周最低:10.80
股本:1.59亿
流通股本:1.44亿
量比:0.64
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-2.9700
每股收益(LYR):-2.9700
净资产收益率:-45.69%
总资产收益率:-27.56%
市净率:3.04
市盈率(LYR):-6.54

数据加载中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities